Article Details

Swiss Biopharma's Future Threatened After Cancer Drug Study Fails to Meet Goals

Retrieved on: 2021-06-28 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

Swiss Biopharma's Future Threatened After Cancer Drug Study Fails to Meet Goals. View article details on hiswai:

Excerpt

Swiss biopharmaceutical company Polyphor has announced that its clinical trial on a potential cure for breast cancer did not meet co-primary endpoints.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up